Coenzyme Q 10 levels are low and associated with increased mortality in post-cardiac arrest patients

Resuscitation

Volumn 83, Issue 8, 2012, Pages 991-995

  Cocchi, Michael N ^a   Giberson, Brandon ^a   Berg, Katherine ^a   Salciccioli, Justin D ^a   Naini, Ali ^b   Buettner, Catherine ^a   Akuthota, Praveen ^a   Gautam, Shiva ^a   Donnino, Michael W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Department of Medicine   (United States)

Author keywords

Biomarkers; Cardiac arrest; Coenzyme Q 10; Cytokines; Inflammatory cascade

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; UBIDECARENONE; DRUG DERIVATIVE; UBIQUINONE;

AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ARREST; HUMAN; MALE; MORTALITY; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETURN OF SPONTANEOUS CIRCULATION; SURVIVAL RATE; BLOOD; HOSPITAL DISCHARGE; MIDDLE AGED; PROSPECTIVE STUDY; SURVIVAL;

AGED; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HEART ARREST; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT DISCHARGE; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UBIQUINONE;

EID: 84863831174     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2012.03.023     Document Type: Article

References (33)

1. Zheng Z.J., Croft J.B., Giles W.H., Mensah G.A. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001, 104:2158-2163.
2. Young G.B. Clinical practice. Neurologic prognosis after cardiac arrest. N Engl J Med 2009, 361:605-611.
3. Bernard S.A., Gray T.W., Buist M.D., et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346:557-563.
4. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002, 346:549-556.
5. Honda H.M., Korge P., Weiss J.N. Mitochondria and ischemia/reperfusion injury. Ann NY Acad Sci 2005, 1047:248-258.
6. 10 as a potential treatment. J Bioenerg Biomembr 2004, 36:381-386.
7. 10 in neurodegenerative diseases. Methods Enzymol 2004, 382:473-487.
8. 10 and remacemide in Huntington's disease. Neurology 2001, 57:397-404.
9. 10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease. Neurosci Lett 2003, 341:201-204.
10. 10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 2002, 59:1541-1550.
11. Peberdy M.A., Callaway C.W., Neumar R.W., et al. Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010, 122:S768-S786.
12. Dare A.J., Phillips A.R., Hickey A.J., et al. A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome. Free Radic Biol Med 2009, 47:1517-1525.
13. 10 ratio as a possible marker of increased risk for atherosclerosis. Biofactors 1999, 9:231-240.
14. 10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol 2007, 49:2231-2237.
15. 10 levels are low and are associated with the inflammatory cascade in septic shock. Crit Care 2011, 15:R189.
16. 10 combined with mild hypothermia after cardiac arrest. Circulation 2004, 110:3011-3016.
17. Curtin F., Schulz P. Multiple correlations and Bonferroni's correction. Biol Psychiatry 1998, 44:775-777.
18. 10 concentrations and redox state in apparently healthy children and adults. Clin Chim Acta 2004, 347:139-144.
19. 10 plasma levels and body composition in elderly males. Arch Gerontol Geriatr 1996, 22(Suppl. 1):539-543.
20. Brealey D., Brand M., Hargreaves I., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360:219-223.
21. Fink M.P. Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 2001, 17:219-237.
22. Harrois A., Huet O., Duranteau J. Alterations of mitochondrial function in sepsis and critical illness. Curr Opin Anaesthesiol 2009, 22:143-149.
23. Neumar R.W., Nolan J.P., Adrie C., et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation 2008, 118:2452-2483.
24. Radhakrishnan J., Wang S., Ayoub I.M., Kolarova J.D., Levine R.F., Gazmuri R.J. Circulating levels of cytochrome c after resuscitation from cardiac arrest: a marker of mitochondrial injury and predictor of survival. Am J Physiol Heart Circ Physiol 2007, 292:H767-H775.
25. Karanjia N., Geocadin R.G. Post-cardiac arrest syndrome: update on brain injury management and prognostication. Curr Treat Options Neurol 2011, 13:191-203.
26. Adrie C., Adib-Conquy M., Laurent I., et al. Successful cardiopulmonary resuscitation after cardiac arrest as a " sepsis-like" syndrome. Circulation 2002, 106:562-568.
27. Hack C.E., De Groot E.R., Felt-Bersma R.J., et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989, 74:1704-1710.
28. Casey L.C., Balk R.A., Bone R.C. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993, 119:771-778.
29. Pinsky M.R., Vincent J.L., Deviere J., Alegre M., Kahn R.J., Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993, 103:565-575.
30. Damas P., Ledoux D., Nys M., et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992, 215:356-362.
31. 10 on the mediator cascade of sepsis. Circ Shock 1993, 39:178-187.
32. Adrie C., Laurent I., Monchi M., Cariou A., Dhainaou J.F., Spaulding C. Postresuscitation disease after cardiac arrest: a sepsis-like syndrome?. Curr Opin Crit Care 2004, 10:208-212.
33. Van Leeuwen H.J., Heezius E.C.J.M., Dallinga G.M., Van Strijp J.A.G., Verhoef J., Van Kessel K.P.M. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003, 31:1359.